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liters per minute.
Venous blood
contains about
12% volume of
oxygen, but
under conditions
of stre.nuous
exercise this may
fall to 3%,
following greater
extraction of
oxygen. Highly
trained endurance competitors may have
an increase in blood volume of up to 50%,
often accompanied by lowering of
haematocrit (percentage of total blood
volume that is red blood cells) and
haemoglobin (a protein in the red blood
cells that binds oxygen), known as sports
pseudo-anemia.
A liter of blood delivers about 200 ml
of oxygen. In our laboratory we have
recorded cases of maximum oxygen
uptake of 4.9 liters per minute. Values of
7 liters per minute have been reported for
large rowers (1,2). In terms of relative
aerobic capacity, values of 66 to 78.8 mil
kg/min. have been reported for elite
athletes in the field of triathlon, cycling,
cross-country skiing and rowing (3,6). As
each liter of oxygen may release 5 kcal
(21 kJ) of energy this implies that the
energy cost of aerobic work may reach
more than 30 kcal (126 kJ) per minute over
periods of up to 10 minutes, and 20 kcals
per minute (84 kJ) are seen in longer
periods of strenuous exercise.
The aerobic test itself is performed on
Adequate delivery to the muscle is
necessary for a wide range of activities
and sports. A resting stroke volume
(volume of blood that is ejected from the
heart at every beat) of 70-80 ml for a
subject who weighs 70kg and who has a
heart rate of 70 beats per minute produces
a resting cardiac output (volume of blood
pumped by each ~entricle per minute) of
around 5 liter5"'per minute. During
strenuous exercise the stroke volume may
increase by 30-40 ml, giving a cardiac
output of 20·25 liters per minute at near
maximum heart rates. In highly trained
athletes, the cardiac output may reach 35
Cardiopulmonary or "aerobic"
fitness
training syndrome. He also must have
weathered the vagaries of selection and
must have sympathetic management.
Finally, the athlete must be physically 'fit'.
There is no single parameter of fitness: it
is a composite which varies from one sport
to another, containing the elements of
cardiopulmonary function, local muscle
endurance, "muscle strength and speed,
joint mobility and body composition. These
will be briefly described.
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One of the many questions asked by
sportsmen is "How fit am I?" or "Am I fit?"
Yet physical fitness is only one factor of
sporting excellence. There are at least
seven other elements one has to consider.
The athlete must be completely competent
in all the techniques of the sport, including
the use of the latest equipment, where
appropriate. The athlete must be expert
in the tactical aspect of the sport and be
psychologically prepared to handle the
enormous stress of critical situations. He
or she must be physical well, free from
physical injury including overuse injury,
current infection, time zone changes,
weather acclimatisation and the over-
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THE
GENOMIC
ERA
April 14, 2003 was claimed as a birth date of the
genomic era and now we are in the second year of the
era. The date is a coincident with the achievement of the
last goal of the Human Genome Project: to complete
sequencing (mapping out) of the human gonome. The
extend and pace of progress in genomics are suggested
by the fact that this achievement occurred 11 days shy of
the 50 tho anniversary of the publication of Watson and
Crick's seminal description of the DNA double helix. Its
scope and potential consequences has much in common
with the International HapMap Project.
The goal of the International HapMap Project which
was formally initiated with a meeting in Washington D.C
on 27-29 October 2002, is to determine the common
patterns of DNA sequence variation in the human genome
and to make this information freely available in the public
domain. An international consortium is developing a map
of these patterns across the genome by determining the
genotypes of one million or more sequence variants, their
frequencies and the degree of association between them,
in DNA samples from populations with ancestry from parts
of Africa, Asia and Europe. The HapMap will allow the
discovery of sequence variants that affect common
disease, will facilitate development of diagnostic tolls, and
will enhance our ability to choose targets for therapeutic
intervention.
Both projects have been scientifically ambitious and
technologically demanding, have involved intense
international collaboration, have been dedicated to the
rapid release of data into the public domain, and promise
to have profound implications for our understanding of
human biology and human health. The sequencing project
covered the entire genome, including 99.9% of the
genome where we all the same; whereas the HapMap
will characterise the common patterns within the 0.1 %
that we defer from each other.
In fact, we already witnessed the advancement in
genomic medicine before this date: the use of genomics
for~~~ rapid identification of newly discovered pathogens
such as that involved in the severe acute respiratory
synprome (SARS); the use of gene-expression profiling
to assess prognosis and guide therapy, as in breast
cancer; the use of genotyping to stratify patients according
to the risk of a disease, such as the long-QT syndrome or
myocardial infarction; the use of genotyping to shed light
on the response to certain drugs, such as antiepileptic
agents; and the use of genomic approaches in the design
and implementation of new drug therapies, such as
imatinib for the hyperesonophilic syndrome, and to
improve our understanding of the role of a specific genes
in the causation of common conditions, such as obesity.
Although genomoics provides powerful means of
discovery of hereditary factor in disease, we should
realised that it is not genes alone but the interplay of
genetic and environmental factors that determines
phenotype (Le., health or disease). Since it remains difficult
to alter genes in human although we are in the genomic
era, (for both technical and ethical reasons), the next
couple of decade, we will generally use personalised
modifications of the environment, but not of genes
translate genomics-based knowledge into improvemen
in health for most of our patients. For examples, clinician
will likely suggest to their patients with hereditary
hemochromatosis that they avoid iron supplement than
that consider gene therapy. Women who carry mutations
in BRCA2 will benefit more from taking tamoxifen than
from manipulations of their genotype.
With the end of pregenomic era in sight, more than
600 experts recently collaborated to produce a vision for
the future genomic research and its application to biology,
health and society. According to that vision, for instance,
within a decade or two, it will possible to sequence entire
genome for a laboratory cost of less than USD $1,000. If
this proves true,one can imagine how not only research,
but also clinical care, may change dramatically. However,
as is true for so much of the applications of genomics;
ethical, legal and social issues complicate this optimistic
picture. The attention must also be paid to the ethical
issues that will be raised by the HapMap and the studie
that will use it. It will be ongoing challenge to avoid
misinterpretations or misuses of results from studies that
use the HapMap.
While recognizing such challenges, we look forward
with curiosity and real hope to the advances of the next
50 years - the first 50 years of the genomic era. Today's
researches and clinicians have already started using the
power of genomics to improve health and we anticipate
this; a hint of the progress to come. It is hope that the
benefit of genomic medicine will not accrue only to people
in developed countries but also for all of the mankind.
Regarding the HapMap Project, it hold much promise as
a powerful new tool for discovery - to enhance our
understanding of the hereditary factors involved in health
and disease.
Profesor Mohd. Razali Salleh
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an ergometer appropriate to the sport: for example, a
treadmill is used for running sports, cycle ergometers
for cyclists and rowing ergometers for rowers. Whatever
the ergometer used, the work rate is increased at
constant intervals until exhaustion while heart rate is
recorded and a variety of respiratory parameters are
~easured and computed on our gas analysis system.
The object is to asses the maximum oxygen uptake
(V021J:1a 'l) which correlates reasonably well with the
athlel:e s aerobic performance.
A very useful parameter to the VO is the
assessment of the 'anaerobic threshold' or th'Etonset of
blood lactate accumulation (OBLA). This is the rate of
work at which plasma lactate reaches 4 mmol/I and it
reflects the percentage of the V0 2 which can be
sustained for the duration of continuous exercise such
as running, cycling, swimming, rowing and canoeing.
Thus the V02I\Ca gives an indication of the potential aerobicpower availaore, while the anaerobic threshold gives a
measure of the current state of training. The anaerobic
threshold may also be measured directly as lactate from
od samples or indirectly by determining at what rate
!xercise or oxygen uptake or heart rate a non-linear
",crease in pulmonary ventilation occurs. The adult
V0 2max may improve by 20% with training and the
anaerobic threshold may be raised from 60% of V02to 80% or higher. max
Over the years runners may decrease the oxygen cost
of running at a particular speed or improve their running
economy, by increasing the biomechanical efficiency of
their running action. These performance economy also
applies to cycling, swimming and rowing.
Local muscle endurance
Local muscle endurance is often termed 'anaerobic
fitness', which is a misnomer, as there is an aerobic
contribution to all supramaximal muscular effort lasting
longer than about 5 seconds. It is needed particularly
for the 'muscular' sports such as judo, wrestling, bOXing
and rowing. It is also vital for the 'multiple sprint sports'
such as squash, badminton, hockey and football in which
rapid successive anaerobic attacks/movements have to
be made throughout the game, against a varying high
aerobic background.
The aerobic elements of muscle endurance depends
_oth on the cardiac delivery of oxygen and the ability of
muscle to utilise it. With training, the number of
capillaries per square millimeter of muscle doubles,
myoglobin may increase threefold and the mitochondria
may increase their volume about threefold.
The anaerobic side of muscle endurance involves the
energy systems of creatine phosphate and anaerobic
glycolysis. The former can be increased three or four
times with suitable interval training. Furthermore,
appropriate interval training will trigger muscle synthesis
of the enzymes involved for glycolysis, considerably
improving the metabolic control mechanism of anaerobic
function.
The increase in the rate of glycolytic anaerobic work
leads to increased production of lacftic acid with its
damaging protons. Blood buffers increase with training,
and there is an increase in Cori cycle function, whereby
lactate is taken up by the liver, the renal medulla and
the myocardium and resynthesised as qlucose. It is not
clear to what extend the other lactate removal systems
are increased with training.
Blood lactate levels of more than 18 mmol/I have
been recorded in events such as slalom canoeing, rowing
and the longer running sprints from a resting level of
around 1.0 mmol lactate per liter. This can lead to a fall
in plasma pH from 7.4 to 7.1. Protocols for optimising
the reduction of lactate removal, involving 'active rest'
interval training have been developed (7).
The most rigorous test of anaerobic function is the
Wingate test plus its variants (8). Developed by Professor
Oded Bar-Or, it is a supramaximal 10-second or 30-
second test whereby the subject works computer linked
ergometry with either his upper or lower body. In our
laboratory, anaerobic leg work is tested by the single
cycle ergometer and the upper body is tested by a
modified arm cranking ergometer (9).
Four results can be obtained from a Wingate test.
First, the peak anaerobic power output, which is
measured in watts. The time to reach this peak may be
a useful measure, particularly in 'off the mark' sports
such as rowing, and sprinting. The mean power sustained
during a 10-second period or 30-second period is a useful
measure of anaerobic endurance, as is the 'fatigue index",
the rate of decline from peak to finish, measured in watts
per second. A rate of decline of less than 10 watts per
second is considered excellent, 10-15 very good, 20 good
and so on.
For the multiple-sprint sports, recovery from one bout
of intense anaerobic activity before sprinting into the
next is one of the most important attributes. This is
assessed by a repeat test at a given time, such as four
minutes, later. The total work done is expressed in kilo
joules and the second test is expressed as a percentage
of the first. A value of 80% would be considered fair at
elite level., 85% would be good, 90% very good and 95%
excellent. Some competitors, especially squash players,
have values of more than 100%; that is, their rate of
recovery is so good that they can take advantage of
their hot muscle to perform a greater volume of work
four minutes later.
Muscle strength and speed.
Weight-lifting and the scrum in rugby, together with
certain situations in artistic gymnastics, judo, karate,
and wrestling require sheer muscle strength. In most
other sports it is not simply high muscle tensions which
are required - the speed is also crucial. This rate of
development of tension is power and it is frequently
important to measure the production of muscle power
throughout a defined range of movement. Sophisticated
isokinetic dynamometers are needed to test these aspects
of muscle function. The muscle force and power at a
speed of movement of 80, 140 or 200 degrees of arc per
second, whatever is appropriate to the sport, is
measured. The faster a muscle contracts, the lower the
force which it develops, although the rate of change varies
with different muscle groups. For example a hamstring
which may only generate 55% of the tension of its
quadriceps antagonist isometrically, may generate 78%
at 140 degrees a second and at 200 degrees a second
give a value of 92% of the quadriceps. Similar variations
are seen when comparing lumbar flexion and extension>
Thus, movement speed is important in assessment of
muscle force.
Joint mobility
Some sports, such as artistic gymnastics and sepak
takraw, require extraordinary ranges of movement at
particular joints. Other sports - karate, hurdling, high
jump and pole vault - also require considerable joint
mobility. many other sports, including games and racket
sports, require a degree of mobility to supply some
degree of prophylaxis against damage resulting from
acute overstretch. Goniometry, preferably in the hands
of a physiotherapist, is the required measure.
Body composition
Assessing body fat is of considerable use to a
sportsman. An athlete may put on a couple of kilograms
during training and may wish to be sure that this is
muscle, not fat. Those in weight-categorised sports may
wish to know of their chances of going into a lower weight
class. If their fat level is relatively high, they may easily
be able to lose the required weight; if their body fat is
low, it may be inadvisable.
Following injury or lay-off, a competitor may wish to
know if fat has been gained during the period, even
though body weight may have remained constant, as
some degree of muscle atrophy may have occurred. A
variety of techniques are available for assessing body
composition. Many of the elite male competitors in a
variety of endurance sports, such as gymnastics have
body fat percentage in the range of 6 to 9%, with females
ranging from 15 to 20%. By comparison, the mean body
fat levels of untrained 20-year-old are 12-14% in males
and 26-28% in females. Hi~h levels of body fat are
essential, however, for long distance sea swimming.
Value of testing
These measurements are most accurate and of
greater use when compared with previous assessments
of the same subject at earlier times i.e. when the subject
acts as his own control. Physiological testing may be
'diagnostic" in pinpointing a unilateral muscle weakness
in a wrestler or a rower, or in establishing that a squash
player is excellent aerobically but relatively poor
anaerobically. It may be helpful to competitors in
complex sports such as hockey, to know that physically
they compare well with others of world class. Track and
field athletes and swimmers, par excellence, are
quantified in every aspect of their training, but in most
other spotts the results of training may not be measured
at all.
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Research in School of Medical Sciences - Rosy
Achievement in 2003
The School of Medical Sciences has been a leader
and continues to maintain leadership in research at
Universiti Sains Malaysia. The money received
through 6th _8th Malaysia Plan thus far $upported 145
long term projects under the Intensified Researchin
Prioritized Areas (lRPA), 296 short term projects, 12
Fundamental researches under the Fundamental
Research Grants Scheme (FRGS), 29 incentive
grants. There is a total of225 lecturers of the School
of Medical ~ ciences as of December 2003, the
majority is in the rank of lecturers, comprising 152
persons. Out of the total number of academic staff,
the non-contract lecturers make up 73.5%. Almost
all of these non-contract lecturers are holding or ha
held research grants and a total of49.4% are princip
investigators. Only 17.1% of the contract lecturers
are or were participating in research.
There is an impressive increasing trend of the number
ofgrants held by the academic staffwith 112 projects
in the 6th, 193 projects in the 7fh and 335 projects for
the 8th Malaysia Plan. The trend is corresponding to
an increase in the number ofacademic staff in SMS.
~
For the 8th Malaysia Plan thus far, we record grant
acquisition ofover 20 million Ringgit, as shown below
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The year 2003 has been a successful year in
research. The medical school of USM records a total
number of 51 papers published in the year 2003 at
national- and international journal, improved from 24
papers published in the preceding year. Thirty three
(33) members of the medical school have received
various awards from winning best research papers
in scientific meetings to innovative inventions at
national and international levels.
Profesor Nor Hayati Othman
Timbalan Dekan (Penyelidikan)
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C INICAL TRIALS - MY EXPERINCES
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INTRODUCTION
Clinical trial or clinical study is an investigation in
human subjects intended to discover or verify the clinical,
pharmacological and/or other pharmacodynamic effects
of an investigational product(s), and/or to identify any
adverse reaction to an investigational product(s), with the
objective of ascertaining its safety and/or efficacy. Clinical
ials may be divided into commercialised and non-
commercialised clinical trials. In the former, pharmaceutical
companies provide the protocol and funds for the
researcher to recruit patients and implement the study and
in the latter; the investigator initiates clinical trials with or
without involvement of the drug companies.
Good Clinical Practice (GCP) is a standard for the
design, conduct, performance, monitoring, auditing,
recording, analyses and reporting of clinical trials that
provide assurance that the data and reported results are
credible and accurate; and that the rights, integrity and
confidentiality of trial subjects are protected (ICH-GCP
glossary 1.24). As long as we follow GCP gUidelines strictly,
we and our patients are safe. At the same time the local
ethical committee will monitor the trials closely. The rule
of 'do no harm' to the patients is very important principle
in clinical trial.
MY EXPE IENCE
My first involvement in clinical trial in 1999 was as a
a-investigator on the new combination of dru\Js for
hypertension. After several clinical trials as cO-Investigator
I was given the opportunity to be the principal investigator
in 2002 in one of the study on diabetes mellitus. To date I
have been involved in about 20 clinical trials including 5
as principal investigator. I was confused when I attended
my first ever GCP workshop at USM in 1997. I was able
to appreciate better with the second workshop in 1999.
Certificate of GCP now is a prerequisite to conduct the
clinical trial. For the past two years I was frequently invited
as facilitator for the GCP workshop run by the Clinical Trial
Unit.
ADVA TAGES OF DO NG CLINICAL TRIALS
1. Advantages to The Inve tigator
a. Extra money
As many people think, money is not the only reason
for doing clinical trials. There are many clinical trials that
do not generate money. Most provide funds just sufficient
to buying drugs, reagents, etc. I've been involved in studies
that gave me good money and other benefits including
travels abroad, as well as in clinical trials that that does
not generate any money. In USM, the budgets for clinical
trials are scrutinised by the ethical committee to ensure
that the investigators do not go overboard in requesting
money from the pharmaceutical companies. The studies
that I have been conducted so far do not provide money
directly to the investigator; however the university provided
grants for PhD and Masters students who are involved in
the trial. In fact, the clinical trials involving post graduate
students really consume much of my time, sometime
including my lunch-holJr breaks. So, the perception that
clinical trials are for generating money only is not true.
b. Travels overseas
The clinical trials may provide an incentive for the
investigators to travel abroad attending meetings with other
collaborators involved in the multi-centre project. This is
the opportunity to learn valuable skill~ fran: their
counterparts, enrich the knowledge of other Investigators
and establish linkages for future work.
c. Academic achievement
Clinical trials- are regarded by the university as private
consultation. The university will consider each grant that
you get from the pharmaceutical company as additional
point for promotion exercise. When doing clinical trials with
post graduate students, assured that you will have a few
publications; it is better aimed for the international journ~1
as the mark is higher. You can also present the data In
conferences; however this is depend on your agreement
with the sponsor.
d. Experience in wei planned clinical trials
Having involved in multi-centre trials, the clinician will
gain confidence to undertake major clinical trials including
benchmark trials. At the moment, I am involving in a long-
term study on diabetes mellitus which will be completed in
2008. It helps me a lot to evaluate the outcome ~f major
trials especially in diabetes, such as United Kingdom
Prospective Diabetic Study.
e. Practice better medicine.
In doing clinical trials one have to follow protocols and
GCP guidelines. The protocols are usually planned by
experts in the field taking into consideration of feedback
from the investigators. The investigators need to inform
and communicate about the trial to the study subjects and
take informed consent. They need to spend adequate time
with their patients to complete a thorough history and
conduct detailed physical examinations; which required
medical competent and good clinical skill. Documentation
of all adverse events, including trivial one such as
toothache is very important in clinical trials. The
investigators should be in contact with their patients
frequently to ensure the safety. If the patient is ho~pitalised,
the investigator will visit the patients and notify to the
sponsored company as well as the ethics committee.
Whenever necessary, the investigator will also do home
visits to see the patient.
f. Gaining experience
The principal investigator is usually the expert in the
field. In the beginning, a new investigator may start as a
co-investigator, learn the art and gradually progress to
principal investigator. For example, as a pnmary care
physician, initially I was not comfortable of initiating insulin
to my patients with type 1 and type 2 diabetes. After my
involvement in the clinical trials with good supervision, I
learnt a lot and now I am comfortable with the technique
and able to teach others on the usage of insulin to out-
patients.
g. Experience with the new drugs
Learning and using new drugs in the trial ahead of
others is another advantage to the clinician. One will be
able to gain knowledge and confident in using the drug,
and educate the others on the advantage and
disadvantage based on this experience.
2. Advantages To The Patients
In general, the participation of subjects in clinical trials
is totally voluntary. They can withdraw anytime during the
study even without any reason. Upon withdrawal, the
relationship with the doctor/investigator and future
treatment won't be affected. The following are some of
the advantages to the patients:
a. Better monitoring and effective screening
In the clinical trial, patients will be followed-up closely
and the medical problems and treatment can be monitored
regularly. Based line investigations such as blood tests,
ECG etc. will help in detecting some of the hidden
problems. For example, when we went to offices and public
places to conducted Oral Glucose Tolerance Tests; we
have detected subjects with diabetes and impaired glucose
tolerance. Otherwise, they would not have been detected
under normal circumstances.
b. Better management.
Usually the investigator is the authority on managing
the problem related to the study. For example
endocrinologist, in a diabetic study, cardiologist in
hypertension studies and so on. They definitely can
manage and treat the patients much better than the general
physician.
c. Better relationship and outcome
Good doctor-patient relationships is established,
especially when the trials is going on for long time (about
5 years). The physician even gives his personal contact
number to their patients.
3. Advantages To The Institution
More trials mean more money for the institution and
the investigatot. The university will collect money by certain
percentage of each project plus an additional percentage
on the excess income of the investigator. The hidden
advantage to the institution is that the investigator with
this extra income feels happy.
4. Advantage to The Pharmaceutical Industries
Clinical trials will help companies advertise its products.
In the era of evidence-based medicine, the trials would
prove or disapprove the beneficial claims of the product.
As mentioned earlier, the investigators are the opinion
leader in their field; after successful trials, the usage of
the products will be extended further down. It is a win-win
situati~n, between the companies and the clinicians that
will result in better patient care.
5. Benefits to The Country
Bring more investment to the country and at the same
time Malaysia will be known worldwide as one of the multi-
center drugs trials.
DISADVANTAGES OF CLINICAL TRIAL
1. Disadvantages to The Investigator
Time consuming and extended commitment. Many time
the subjects called me and asking for non-related problems
that I have to entertain and document it. This will take up
my valuable time beside the burden of evaluating whether
the situation warrants immediate attention or not.
2. Disadvantages to The Patient
In any drug trial, there is always a risk of developing
side effects especially if the trials are at the earliest stage.
Of course patient's safety is our foremost importance. One
of my clinical trials was abandoned abruptly when thE.
company realised the possibility of developing bladder
carcinoma on high doses of the compound. The patients
were subsequently screened on a yearly basis for the
malignancy but so far, there are no reported cases of
bladder carcinoma on the participants involved globally.
3. Disadvantages to The Pharmaceutical Industries
They will be a great loss if the outcome of the trials do
not favour them or if they have to stop further development
of the new drugs. The company may lose billion of dollars
and a drop in the share market may ensue if the study is
stopped half-way. We know for sure that if the outcome
does not favour the sponsor, it is unlikely to publish the
result unless the sponsor is an independent body. For
example, the outcome of one of our clinical trials completed
in 1999 is still not sent for publication by the sponsor. The
likely cause is that the result is not good for them.
CONCLUSION
If you are a clinician and GCP certified, you can be an
investigator; but you must give full commitment in order to
make it successful. Clinical trials have many advantages
to the clinicians including primary care physicians,
pharmaceutical industries, institutions, country and to
certain extend, patients participated in the trials. It is noted
that more and more trials will be coming to this part of the
world and hopefully all of us will get the benefit out of it.
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DEPARTMENTAL RESEARCH ACTIVITIES
DEPARTMENT OF MEDICINE
THE CURRENT FUNDED RESEARCH ACTIVITIES IN WHICH THE DEPARTMENT STAFF MEMBERS
ARE THE PRINCIPAL INVESTIGATORS
No. Title )0 Grant Type / Staff Member
Funding Body
1. Asix months, multi-centre, open, randomized, parallel safety and efficacy Novo Nordisk Prof. Wan Mohamad Wan
comparison of Actrapid produced by the current process and human insulin with the Bebakar
same formulation as Actrapid, produced by the NN 729 process in subjects with
type 1 diabetis on a basal/bolus regimen
2. Acute dialytic support for the critically ill. Continuous venovenous haemodialysis USM short term Dr. Kamaliah Mohd Daud
versus continuous venovenous haemofitration
3. Understanding the Mechanism of Systemic Lupus Erythematosus -the Role of Th1 FRGS Grant Dr. Kamaliah Mohd Daud
and Th2 Cytokines
I. A multicentre, randomized, double-blind, parallel group, placebo-controlled study to Glaxo-Smithkline Dr. Che Wan Aminuddin Hashim
investigate the long term effects of salmeterol/fluticasone proprionate (SERETIDE)
50/500ug bd, salmeterol 50ug bd and fluticasone 500ug bd, all delivered via
ACCUHALER inhaler, on the survival of subjects with chronic obstructive pulmonary
disease (CaPO) over three years of treatment
5. A Multicenter, Double Blind, Randomized, Placebo-And Active-Controlled, Parallel Merck Sharp Dome Profesor Mafauzy Mohamed
Study to Evaluate the Glucose and Lipid-Altering Efficacy and Safety of L-410198
(MK-0767) in Patients with Type 2 Diabetes
6. A Multicenter, Randomized, Double Blind Study to Evaluate the Safety and Efficacy Merck Sharp Dome Profesor Mafauzy Mohamed
of MK-0767 Monotherapy in Patients with Type 2 Diabetes Mellitus
THE CURRENT FUNDED RESEARCH ACTIVITIES IN WHICH THE DEPARTMENT STAFF MEMBERS
ARE THE CO-INVESTIGATORS
No. Title Grant Type / Staff Member
Funding Body
1. The association of HLA class II antigens with anti-cardiolipin antibody expression USM short term Dr. Kamaliah Mohd Daud
in Malay patients with systemic lupus erythematosus in Hospital Universiti
Malaysia
2. Role of anti-nucleosome antibodies as a disease marker in SLE and it's correlation USM short term Dr. Kamaliah Mohd Daud
with disease activity.
3. The relationship between stone chemical composition and urinary biochemical USM short term Dr. Kamaliah Mohd Daud
abnormalities in urinary tract stone formers in Kelantan
4. Human Acetyltransferase Polymorph isms : A Pharmacogenomic and IRPA Dr. Che Wan Aminuddin Hashim
Pharmocokinetic Study of Isoniazid in Tuberculosis
5. Risk Management of Occupational Asthma IRPA Dr. Che Wan Aminuddin Hashim
6. Atrial Fibrillation Clopidogrel Trial with Ibesartan for prevention of Vascular Events Sanofi-Synthelabo Dr. Mohd Sapawi Mohamed
RESEARCH PROJECTS SUBMITTED FOR FUNDING BY THE STAFF OF THE DEPT. OF MEDICINE
No. Title Grant Type / Staff Member
Funding Body
1. Detection of PIA2 gene polymorphism of platelet glycoprotein USM short term Dr. Atul Prasad
(GPllla) in patients with migraine headache
NON FUNDED RESEARCH PROJECTS IN WHICH THE DEPARTMENT STAFF ARE SUPERVISORS
(MAIN OR CO-SUPERVISOR) OF POST-GRADUATE STUDENTS
No. Title Name of Student Staff Member
1. The Study of Outcome and Survival of Patients with Chronic Myeloid Leukemia in Dr. Mat Zuki Mat Jaeb Professor Abdul Aziz Baba
Hospital Universiti Sains Malaysia and Hospital Kota Bharu - A Retrospective (M.Med)
-Analyst
2. Quality of Life Among Patients on Regular Haemodalysis Comparing Diabetic Dr. Amir Ramli Assoc. Prof. Zainal Darus
Versus Non-Diabetic Groups (M.Med)
3. Carotid Intima-Media Thickness as an Independent Predictor of Coronary Artery Dr. Wan Mohd Razin Assoc. Prof. Zurkurnai Yusof
Wan Hassan (M.Med)
4. Clinical Review of Warfarin Usage in Clinical Practice Dr. Siti Khairani Zainal Assoc. Prof. Abdul Rashid Abd.
Abidin (M.Med) Rahman
5. Pattern of Typhoid Fever Among Adult Patients in HUSM and the Outcome of Dr. Wan Hasnul Halimi Assoc. Prof. Zainal Darus
Treatment Comparing Ceftriaxone .Versus Chloramphenicol Wan Hassan (M.Med)
PREPARED BY: PROF MADYA ZAINAL DARUS (HEAD OF DEPARTMENT)
R Er 0 ACTIVITIES IN PPSP
R£S£ARCfi AND D£V£LOP£HN£T (R&D) ACTIVITI£S IN PPSP
(DATA DIKEMASKINIKAN SEHINGGA 25/2/04)
SENARAI PROJEK IRPA (RM 8-EA) YANG DllUlUSKAN DAAI 1/11/83
JABATAN TAJUK PENYELIDIKAN PERUNTUKAN
Farmakologi Effects of P-Glycoprotein inhibitors on chloroguine/ mefloquine resistant malaria model system in vitro: RM 172,000.00
towards identifying chemosensitizers for malaria
SENARAI PROJEK GEAAN PENYEIDIKAN FUNDAMENTAL (FRGS) YANG DllUlUSKAN DARI 1111/83
JABATAN/ TAJUK PENYELIDIKAN PERUNTUKAN
UNIT
Pembedahan The mRNA expression of inducible nitric oxide synthase and its role in tocotrienol treated human keratinocysts RM 98,841.00
Plastik and skin fibroblast in-vitro in normal and hypertophic scar
Pediatrik Undersatbding the role of survival motor neuron 1 (SMN) and neuronal apoptosis inhibitory protein (NAIP) genes RM 78,500.00
in the pathogenesis of spinal molecular atrophy (SMA) patients
I Patologi Molecular characterization of ret/PC mutation in normal, benign and malignant thyroid lesions. RM 79,615.00
SENARAI PROJEK GERAN INSENTIF YANG DllUlUSKAN DARI 1III 183
JABATAN TAJUK PENYELIDIKAN PERUNTUKAN
Pendidikan Survey of lecturers' lifestyle in School of Medical Sciences, USM RM 1,000.00
Perubatan
Pediatrik Determination of the common cystic fibrosis gene mutations in Malays RM 1,000.00
Oftalmologi Cross sectional study to determine visual impairment and ocular abnormality among preschool children in RM 1,000.00
Kelantan
PEMENANG-PEMENANG ANUGERAH 01 lENA lINTERNATIDNAlE RUSSTEllUNG IDEEN-
ERFINDUNGEN-NEWHEITEN), 38 OKT - 2 NOU 2883, NURENBUAG, JEAMAN.
I NAMA PEMENANG KATEGORI HADIAH TAJUK
PROFESOR ASMA ISMAIL PINGAT EMAS TYPHIRAPIOS
I PROFESOR NOR HAYATI OTHMAN PINGAT GANGSA NEURALPAP
AKTIUITI-AKTIUITI BAHAGIAN PENYElIDIKAN, PUSAT PENGAJIAN SAINS PERUBATAN TAHUN 2884
1. Kursus Intensif Metodologi Penyelidikan (untuk pensyarah)
Tarikh : Mac 2004
Tempat : Bilik Tutorial 18,
Jabatan Pendidikan Perubatan
Bilangan Kehadiran : 70 orang
2. Kursus Intensif Biostatistics & Hands-On Statistical Software Application (untuk pensyarah)
Tarikh : Mac 2004
Tempat : Bilik Persidangan Utama & CAl Lab
Bilangan Kehadiran : 70 orang
3. Bengkel Penyediaan Tesis dan Disertasi Berkualiti (untuk pelajar sarjana)
Tarikh : April 2004
Tempat : Dewan Kuliah 1,
P.P. Sains Pergigian
Bilangan Kehadiran : 150 orang
4. Bengkel File Maker Pro Asas (untuk stat R&D)
Tarikh : April 2004
Tempat : CAl Lab
Silangan Kehadiran :15 orang
MESYURRRT YRNG DITETRPKRN
1. Mesyuarat Jawatankuasa Penyelidikan & Etika, PPSP
Tarikh : 2 kali sebulan
Tempat: Bilik Mesyuarat Dekan, PPSP
Bilangan Kehadiran : 30 orang (+ penyelidik dibilik menunggu)
2. Mesyuarat Khas JK Penyelidikan & Etika, PPSP
Tarikh : 2 bulan sekali
Tempat : Silik Mesyuarat Dekan, PPSP
Bilangan Kehadiran : 18 orang
3. Mesyuarat Timbalan Dekan. (Penyelidikan) Dengan Pegawai Sains
Tarikh : 3 bulan sekali
Tempat : Dimana-mana bilik mesyuarat yang akan ditentukan
Bilangan Kehadiran : 25 orang
4. Mesyuarat Timbalan Dekan (Penyelidikan) Dengan Stat Bahagian Penyelidikan
Tarikh : 1 kali sebulan
Tempat: Bilik Mesyuarat Dekan, PPSP
Bilangan Kehadiran : 12 orang
HILAn IOUS COLUMN-H ILAn IOUS COLUMN-H ILAn IOUS COLUMN-H ILAn IOUS COLUMN
HAPPINESS & LONGEVITY
To be happy with a man, you must understand him a lot and love him a little. To be happy with a woman,
you must love her a lot and not try to Understand her at all.
-Dr. Nazihah (M.Med-Rad)
CONFLICT
"A woman, about to be married, asked her mother what to wear on her wedding night. 'Wear a heavy, long,
flannel nightgown that goes right up to your neck. But when she asked her best friend, she got conflicting
advice. 'Wear your most sexy negligee, with a V-neck right down to your navel."
-Dr. Hj. M. Abdul Kareem (Rad)
DISCREDIT
In a New York park, a young boy was attacked by a crazy, savage dog. A passerby came to the rescue.
Having tackled the dog, he strangled it to death, and saved the young boy. A reporter for a newspaper who
happened to be there took snap shots. Approaching our hero the reporter says:
" Your heroic feat shall be published in tomorrow's paper under the headline - Brave New Yorker rescues
boy". " I'm not from New York", replied our brave hero.
"Oh in that case, we'll change the headline to - Brave American rescues boy from savage dog ". " I'm not
American either", replied our brave hero. On being asked about who he really is? Our hero replied "I'm a
Pakistani".
The next day the headline on the front page of the paper said: "A Muslim Fundamentalist strangles an
innocent American dog to death in New York park. FBI are investigating possible link to the AI-Qaeda."
-Dr. Muhamad Hanafiah (M.Med-Rad)
J
ABSTRACT OF THE SELECTED PUBLICATION FROM ACADEMIC STAFF PPSP
Title of the article
Genetic polymorphism of CYP2D6 in Chinese subjects in
Malaysia.
Name of the Journal
Journal of Clinical Pharmacology and Therapeutic 2003;
28(4):279-284
Authors
Ismail Rl, Teh LK, Amir J, Alwi Z, Lopez CG.
lDepartment of Pharmacology, School of Medical
Sciences, Univ~rsiti Sains Malaysia, Health Campus.
ABSTRACT
Background: Although Malaysian Chinese share an origin
. 1 the mainland Chinese, their evolution has been
uenced by intermarriages. With a gene such as
CYP2D6, which is highly polymorphic, it is expected that
the Malaysian Chinese would exhibit a polymorphism
profile different from those of the Chinese populations in
other geographical locations.
Objective: To study the genotype distribution of CYP2D6
among the Chinese people in Malaysia.
Method: We obtained DNA from 236 Chinese individuals
in Malaysia and used PCR-based methods to identify any
common CYP2D6 alleles.
Results: A total of 236 subjects were enrolled and were
successfully genotyped. Malaysian Chinese were relatively
heterogeneous in terms of their CYP2D6 genotypes with
nine genotypes recorded. CYP2D6 *4, *5, *9, *10 and *17
were detected with the most common genotype being *1/
*10. No subject had genotypes that predicted poor
metabolic activity. However, 40% showed genotypes (e.g.
CYP2D6*10/*10, *17, *4 and *9 and *9/*9) that predicted
intermediate metabolizer phenotype. Another subject
ried the defective CYP2D6*17 allele and six carried
the defective CYP2D6*9 allele. Both these alleles have
not been reported in other earlier Chinese studies.
Conclusion: This study revealed that, in terms ofCYP2D6
polymorphism, Malaysian Chinese were a heterogeneous
group of people. Although sharing some similarities with
other Orientals, they also seemed to have some notable
differences. The alleles CYP2D6*4, *5, *9, *10 and *17
were all detected. CYP2D6*3 was however absent.
Title of the article
Classification of Cervical Cancer Cells Using HMLP
Network with Confidence Percentage and Confidence
Level Analysis
Name of the Journal
International Journal of The Computer, The Internet and
Management 2003; 11(1):17-29 .
Authors
N. A. Mat-Isa, M. YMashor, N. H. Othman
Pathology Department, School of Medical Sciences,
Universiti Sains Malaysia, Health Campus. .
ABSTRACT
In most previous studies, the analysis on the ability of
neural networks to be used as a good cervical cancer
diagnosis technique is only based on accuracy, sensitivity,
specificity, false negative and false positive. In the current
study, we go one step further by introducing analysis of
diagnosis confidence percentage and diagnosis
confidence level to analyses the ability of neural network
to produce a good diagnosis performance. The current
study used hybrid multilayered perceptron (HMLP) network
to diagnosis cervical cancer in the early stage by classifying
cervical cell into nOrn1al, LSIL and HSIL cell. The proposed
diagnosis confidence percentage and diagnosis
confidence level analysis have been proved to give clearer
picture on the strength or confidence level of each
diagnosis, which is done by HMLP network.
Keywords : Cervical cancer, HMLP network, diagnosis
confidence percentage, diagnosis confidence level, Pap
test.
Title of the article
Multicentre laboratory evaluation of Brugia Rapid dipstick
test for detection of brugian filariasis.
Name of the Journal
Tropical Medicine and International Health. 2003; 8(10):
895-900.
Authors
Rahmah Nl, Shenoy RK, Nutman TB, Weiss N, Gilmour
K, Maizels RM, Yazdanbakhsh M, Sartono E.
1Department of Medical Microbiology & Parasitology,
Universiti Sains Malaysia, Health Campus.
ABSTRACT
A multicentre evaluation of the Brugia Rapid dipstick test
was performed using 1263 serum samples in four
international laboratories, i.e. T.D. Medical College (TDMC, .
India), National Institutes of Health (NIH, USA), Swiss
Tropical Institute (STI, Switzerland) and Leiden University
Medical Centre (LUMC, Netherlands). In comparison with
microscopy, the dipstick demonstrated sensitivities of
97.2% (70 of 72) at TDMC, 91.6% (175 of 191) at LUMC
and 100% (six of six) at STI. Sera of chronic patients
showed a positivity rate of 11.3% (19 of 168) and 61.2%
(710f 116) at TDMC andLUMC, respectively. AI1266sera
ofnon-endemic normals from STI, NIHandLUMC tested
negative with the dipstick. At LUMC, sera of 'endemic
normals' (amicrofilaraemics with no clinical disease) from
an area with approximately 35% microfilaria positivity
showed 60.8% positive results (31 of 51), thus
demonstrating the likelihood of many cryptic infections
occurring in this population. Specificities of the test with
Onchocerca volvulus sera were 988% (80 of81) and 100%
(10 of10) at the NIHandSTI, respectively,' while specificity
with Loa loa sera at the NIH was 84.6% (44 of52). At the
STI, the dipstick test also demonstrated 100% specificity
when tested with 75 sera from various protozoan and
helminthic infections.
similar to that ofthe Brttish students.
Title of the article
Skeletal union following long bone reconstruction using
vascularised fibula graft.
Name of the Journal
Singapore Medical JournaI2003,' 44(6): 286-287
Authors
Imran Y, Zulmi vv, Halim AS
Departmentof Orthopaedtcs, SchoolofMedtcalSciences,
Universiti Sains Malaysia, Health Campus.
Title of the article
Clinical experience of medical students in a developing
country.
Name of the Journal
Educational Health 2003; 16(2):163-75.
Authors
Malik AS, Seng QBI.
1Department of Paediatric, School of Medical Sciences,
Universiti Sains Malaysia, Health Campus.
ABSTRACT
Thirteen patients had skeletal reconstruction using
vascularisedfibula graft following resection ofthe diseas .
bone. Elevenpatientshadreconstruction ofthe lowerlinh,
and two patients of the upper limbs. Clinical and
radiographlcal eVidence union were achieved with the
average time of32 weeks (earliest eight weeks). Six out
of 11 patients (54%) in lower limb reconstruction started
weightbearing at the average of27 weeks. Bony union in
this study is comparable with other studies using
vascularised fibula graft.
_...-.._~
~.~o I.e's
--.g~ty,
_ .......-.__ -t ey
<>
hh1g
£ r ~.
g=n..ore i-t,
a,=n..d-they
o=n..'-t l..i£-t a,
£ir1ger
Objective: This paper compares the clinical experience
in acute conditions of the undergraduate students of a
medicalschool from a developing country (Malaysia) with
those from a developed country (UK).
Method: This study was conducted at the School of
Medical Sciences, Universiti Sains Malaysia (USM).
Through questionnaire survey enquiry was made about
27 acute medical conditions (ie. condttions related to
internal medicine, paediatrics, andpsychiatry), 15 acute
surgical conditions (i e. conditions related to general
surgery,' orthopaedics, ophthalmology, otorhinolaryngology,
gynaecology and obstetrics), 15 surgical operations and
26 practical procedures. The results obtained were
compared with published data from the UK
Results: Acute medical conditions were seen by higher
numberofthe USMstudents but with less frequency than
the British students. The USM students saw practical
procedures more frequently than the Brttish students dtd,
butalmostan equalnumberperformedthese procedures
independently. The Brttish students attended surgical
operations more frequently than the USM students did.
Conclusion: Given the limitations of comparison
(epidemiological, cultural and geographical differences,
conventional curriculum (in the Brttish medical schools)
vs. problem based learning curriculum (in the Malaysian
medical schoo!)) the overall clinical experience of the
medicalstudents in the USMandthe UKwas comparable.
The USM students had more opportumties to observe
cases and procedures but "hands on" experience was
ABSTRACT
PPSP RESEARCH UPDATE
GEOGRAPH IC INFOR~ATI ON SYSTEM (G IS) AND
REMOTE SENS ING IN MAPP ING OF CH ILOREN
WITH MALNUTR ITI ON - AN INTROOUCTI ON
Zabidi Azhar Mohd Hussin MRCP (UK), FRCPCH,
Syahrul Hisyam Baharudin B Eng. (Aerospace)
The Geographic Information System (GIS) is a
satellite-based system tbat has been used widely in a
number of settings from civilian to military use. Using
this system, one is able to map accurately a location on
, the ground such as earthquake areas, river flow, and
military build up.
This system has been used to map population with
infectious diseases such as Malaria and AIDS with great
successes. Previous studies on malaria have
demonstrated the usefulness of GIS by providing clues
r further analysis of the disease. The display of data
'rtaining to the study area provided an overview of the
malaria incidence in relation to geographically and
ecologically important entities. The same approach can
be used for mapping malnourished children in Malaysia.
Published data have shown that the precise distribution
of malnourished children in Malaysia is largely unknown.
Studies have often been isolated and have shown
pockets of problems scattered throughout the country.
As an example, a study in Kula Lumpur in 1992 noted
that the percentage of preschool children from urban poor
households with inadequate intakes of calories and
nutrients is two to three time higher then those from the
"advantaged group. A study in Sarawak also noted that
81.9% of children are malnourished. Zulkifli and his
colleagues in Kelantan also noted other 'pockets' of
malnutrition among the underserved. These 'pockets'
of malnutrition are often related to children living in
undeserved areas such as the resettlement villages,
aboriginal population, squatters and fishing villages. It
would not be at all surprising that other areas of these
isadvantaged children would be discovered if studies
e done elsewhere. It would be obvious that scattered
"nowledge like this would make policy decision difficult
and manpower planning inaccurate. There is therefore
a logical need to be able to use existing technology to
improve on this problem and provide accurate data to all
concerned with the welfare of these children.
The burden of malnutrition to the country is fairly
obvious. Significant links have been established between
poverty, malnutrition and outcome. It is clear that children
living under multiple hardships often have c:: poorer
outcome measure such as lower la, low rates of school
completion and delfnquency. Socioeconomic inequalities
have also been shown to have an adverse link to
cardiovascular mortality. Present available data in
Malaysia has adequately shown that social and medical
inequalities are present between various states in the
country and also between different socio-economic
groups.
The coverage of Health accessibility of children in
Malaysia is good. It would be a wonderful opportunity if
we could design a study that utilizes ready-made data
present in all these Health Clinics and relate them to the
geographical area where these families live. At present,
routine anthropometrics measurements are done in
children during their attendance at regular immunization
clinics. Data integration from these measurements and
linking them to the GGIS would be a logical step towards
having a map of these families. Other technologies would
be necessary to supplement these data. The use of the
Global Positiong System (GPS) to accurately locate
these families would then be the next logical step. Having
an effective easy-to-use affordable database system that
could be developed to 'capture' these measurements into
a central depository can then further refine the system.
Such a data-base, when linked to facilities such as the
Geoinformation System (GIS) would enable those
planning for the tare of children in this country to target
their resources to the most vulnerable group of children
in need of assistance.
The workflow for such initiatives is as shown:
I; I n I., 1I~ I\,tl'lt!#
Data t:W~.
Entry~
+----
Cl9l!'Jq!f!lQ If)ra(p(J) oUC)1f"1
qq".(lIMI
A pilot study is currently undertaken in the district of
Tumpat, Kelantan to map areas of-malnourished children
in area, considered as one of the poorest areas in
Malaysia
Our visits to the district clinics in this area has brought
us into contact with 2000 young children since the project
started 3 months ago. From initial analysis, we
discovered that more than 30% of these children are
malnourished but appeared completely acceptable by
their families and even the health workers. Data from
this initial study is currently being analyzed. At the same
time accurate geographical location and other socio-
demographic data of the children will be superimposed
and then transferred to an overall geographical map
allowing the researchers to link factors that would provide
further information on the precise location of these
malnourished children and the surrounding locations. At
the same time, data from previously taken National
Census will aid us on understanding the demographic
information in this area.
Our next phase of the study will be to have a period
of intensive intervention to the targeted group, hoping to
reverse the trend of malnutrition to these unfortunate
children. By re-plotting the follow up study results on the
GIS, one would be able to do an accurate follow up
analysis on trends of the problem of malnutrition and
hopefully provide health workers an immediate
intervention plan, relevant to all.
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PCR MRDE ERSY - WITH EZDNR RMP
One of the most significant discoveries in the
field of biotechnology is the polymerase chain reaction
(PCR). PCR is a process of in vitro enzymatic
amplification of a specific region of DNA, using a reaction
mixture containing a DNA polymerase, nucleotides,
buffer, a small amount of DNA as starting template and
its complementary pair of primers. The reaction mixture
undergoes thermal cycling to produce about a million-
fold DNA copies, generating sufficient material for
analysis. At School of Medical Sceinces, Universiti Sains
Malaysia (USM), research team headed by Dr. M.
Ravichandran have developed a simplified
thermostabilized kit for DNA amplification by PCR called
EZDNA Amp. The other researchers involved in the
development of this product are Dr. P. Lalitha, Lee Su
Yin, Lim Kun Lee, Melissa Chan Li Ann, Syed Atif Ali,
Kurunathan a/I Sinniah and Nor Hayati Ismail
The EZDNAAmp contains all the necessary reagents
for a PCR reaction (except primers and DNA template)
in a single tube. All reagents are thermostabilized for
easy transportation without cold storage, making it highly
accessible to underdeveloped countries. EZDNAAmp can
be used for amplifying DNA from all types of organism,
making it ideal for use in all molecular diagnostic
laboratories, such as medical diagnostics, agricultural
research, environmental studies, and veterinary
research.
The preparation of PCR reaction mixture is made
easier by using EZDNAAmp. The user can perform PCR
in 3 simple steps: 1) Add water to reconstitute the
reagents, 2) Add primer" pair, 3) Add DNA sample and
place in thermal cycler.
Product highlights:
Single tube test
Easy to use - only 3 pipetting steps involved: just add
water, primers and DNA sample
Reduces pipetting error and carry-over contamination
Value added - includes an EZDNAAmp Positive Control
and a 25mM gCI reagent "
Easy storage and transportation - no cold chain
required
Inexpensive and affordable
Requires no skilled manpower
Ideal for use in all molecular diagnostic laboratories
Creative educational tool for teaching PCR in schools
The EZDNA Amp received Silver medal at EXP
Science and Technology 2003 organized by Ministry
Science, Technology and Environment (MOSTE). Also
this product has been selected by the Technology
Incubation and Funding Partnership (TIFP) program of
USAINS, USM, as one of the top 10 products of USM
which has commercialization potential.
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been to built a foundation for helping the deaf and hope to
fight for their betterment including free hearing aids and
cochlear implants.
Associate Prof (Dr) Din Suhaimi Sidek is married to Dr.
Norhani Abd Rani, his junior in the University of Tanta.
They studied together while in London till she completed
the Fellowship in Dental Surgery and MSc.in Periodontology.
The couples are bestowed with 4 children, of which 3 of
them are in the higher learning institutions. Both of them
hope to serve the government and people of Malaysia and
the world in the best means.
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1. ]K Penyelldlkan at Etlka 31 Disember 2003 6 ]anuarl 2004
(Rabu) (Selasa) , "
2. ]K Penyelldlkan at Etlka 14 Januarl 2004 20 ]anuarl 2004· -.
(Rabu) (Selasa)
3. )K Penyelldlkan at Etlka 21 Januarl. 2004 10 februarl 2004
(labu) (Selasa)
4. JK Penyelldlkan at Etlka 19 Februarl 2004 25 Februarl 2004
(Selasa) (Rabu)
5. )K Penyelldlkan at Etlka 03 Mac 2004 09 Mac 2004
(Rabu) (Selasa)
6. JK Penyelldlkan at Etlka 18 Mac 2004 24 Mac 2004
(Khamls) (Rabu) ~
7. JK Penyelldlkan at Etlka 31 Mac 2004 06 April 2004
(Rabu) (Selasa) .,. "
8. ]K Penyelldlkan at Etlka 15 April 2004 21 April 2004
-
:..
(Khamls) (Rabu) ) ,,'
9. JK Penyelldlkan at Etlka 30 April 2004 05 Mel 2004
(Ahad) (Rabu)
10. ]K Penyelldlkan at Etlka' 12 Mel 2004 18 Met 2004
(kabu) (Selasa)
11. JK Penyelldlbn at Etlka 2 Jun 2004 08 Jun 2004
(Rabu) .(Selasa)
12. JK Penyelldlkan at Etlka 17 Jun 2004 23 Jun 2004
(Khamls) (Rabu)
13. ]K Penyelldlkan 8[ Etlka 30 Jun 2004 06 Julal 2004
(Selasa) (Selasa) , !
14. JK Penyelldlkan at Etlka 15 Jula! 2004 21 Julal 2004 "
(Khamls) (Rabu) J. :j <1
5. JK Penyelldlkan at Etlka 28 Julal 2004 0301052004 ~
(Rabu) (Selasa)
16. JK Penyelldlkan at Etlka 12 Ogos 2004 18 Ogos 2004
(Khamls) (Rabu)
17. JK Penyelldlkan 8[ Etlka a1 September 2004 07 September 2004
(Rabu) (Selasa)
18. )K Penyelldlkan at Etlka 16 September 2004 22 September 2004
, (Kham!s) (Rabu)
19. )K Penyelldlkan 8[ Etlka 30 Setember 2004 as Oktober 2004
(Khamls) (Selasa)
20. )K Penyelldlkan at Etlka 14 Oktober 2003 20 Oktober 2004
(Khamls) (Rabu)
21. )K Penyelldlkan at Etlka 03 November 2004 09 November 2004
(Rabu) (Selasa)
22. )K Penyelldlkan 8[ Etlka 18 November 2004 24 November 2004
(Khamls) (Rabu)
23. JK Penyelldlkan 8[ Etlka 01 Disember 2004 07 Disember 2004 •
"(Rabu) (Selasa)
24. JK Penyelldlkan at Etlka 16 Disember 2004 22 Disember 2004
(Khamls) (Rabu)
Associate Prof. (Dr.) Din Suhaimi
Sidek was born and spent his early
childhood in the state of Negri
Sembilan. He was groomed in the
prestigious secondary institution,
Malay College Kuala Kangsar also
known as "Eton of the East" before
proceeding to the Middle East in 1977.
He obtained his MBChB from the
University of Tanta, Egypt in 1984 and
started his career as a doctor, first in
the Hospital Besar Kuantan as a house
officer and later as a medical officer in
the Surgical Department. He also had
an opportunity to enjoy his district
posting as the Medical and Health
Officer in Bandar Bera, Temerloh where
he learned how to survive with limited
electricity and water supply and
venturing into the remote areas to
render service to the orang asH. He
was transferred back to Kuantan after
a year before he resumes the training
post of Registrar in ENT at Penang
General Hospital in April 1987.
He joined the School of Medical
Sciences, USM in December 1988 and
soon after that in May 1989 was sent
to Universiti Kebangsaan Malaysia
(UKM) for the postgraduate training.
He completed the MasterS of Surgery
(Otorhinolaryngology-Head and Neck
Surgery) in May 1993 and went to
London in September 1993 to pursue
his MSc (Audiological Medicine) in
University College London. He had the
opportunity to do research for his MSc
in the world famous temporal bone lab
at the Institute of Laryngology and
Otology, London under the supervision
of Professor Leslie Michaels. His
teachers also included Professor David
Kemp (founder of the otoacoustic
emissions) Professor Linda Luxon and
Professor A. Davies. He continued
another year in the Royal Throat, Nose
and Ear hospital as well as in the
Nuffield Hearing and Speech Centre for
Pediatric Audiology. There he had the
opportunity to attend the clinics of Dr.
Navnit Shah (famous for his Shah
Gommet) and observed the surgery by
renpwn Surgeons such as Dr TR Bull,
Dr.Valerie Lund, Dr.David Howard and
Dr. Tony Cheeseman. While in UK he
actively participated in student
activities and was the
President of the
Kesatuan Melayu
United Kingdom.
When he was in
United Kingdom he also
visited. centres such as
the Neurosurgery
I
Institute in Queen's
Square, Great Ormond
Street Children
Hospital, London, the
Audiology Units in
Universities of
Southampton and Nottingham, the
Deaf centres and schools around
London and, the Royal National
Institute of the Deaf. The exposure to
all the centres inspired him to
modernize the service of audiology in
Malaysia after his return in 1995. To
further enrich his experience in 1997
he attended a one-month course in the
United States at the International
Centre for Otologic Training, Savannah.
He was also offered a one-month WHO
fellowship in 2002 where he visited the
states of North Carolina and Georgia,
and attached to the Hearing Screening
and Cochlear implant programs.
In the field of audiology, his main
research was on Hearing Screening.
He did a study on "Hearing screening
of infants of the Special Care Nursery,
UKM with brainstem auditory evoked
potential" in 1992. "A study of
histopathological changes affecting the
inner ear in Acoustic Neuroma"
conducted at the London temporal
bone laboratory in 1994. He received
a long term IRPA grant (1998 - 2002)
entitled "A study of the High Risk
Factors for Deafness and Problems of
Rehabilitation among the Deaf Children
in Kelantan". He developed the
audiology service and research
facilities and with that he supervised
several M-Med dissertations such as
"A study of the Prevalance of ear
diseases among the population of
Tumpat, Kelantan. October 1998 - Mac
2000" ; "Newborn hearing screening
in the special care nursery of Hospital
Universiti Sains Malaysia-2002" ; "An
evaluative study of Distraction Test and
TOAE in Detection of Hearing
Impairment in Early childhood" ; "The
Predictive value of tympanometry in
otitis media with effusion" ; "Faktor
malnutrisi dan sosial terhadap penyakit
otitis media kronik di kalalngan kanak-
kanak di Kelant~n" ; "Praktis jururawat
dalam Penyarlngan Pendengaran
Kanak-kanak di Klinik Kesihatan". In
the year 2004 a nationwide study on
the National survey on Hearing and Ear
diseases will be undertaken with the
Kementerian Kesihatan Malaysia. This
is in accordance with the
recommendation of the WHO that
every country should have its own data
on hearing.
Assoc.Prof (Dr) Din Suhaimi also
has interest in natural products for use
in the ear and has done several studies
including "A study to assess the
efficacy of Gamat on the healing
process of traumatic tympanic
membrane perforations in guinea pig"
and "In-vitro evaluation of the growth
enhancing or cytotoxic effect of
Sticophus horrens (Gamat) fibroblast
cell Line cultures". He will soon be
studying on the cytotoxic effect of Tee-
tree oil on Human Keratinocyte and
fibroblast cell lines cultures. His other
research interest includes sleep apnea
whereby he has supervised a pilot
study on prevalance of sleep apnea
among USM population and another
on children with tonsils and adenoids.
He also attended several sleep apnea
courses locally and abroad. With that
research interest, the sleep stu..l..
laboratory was established in the 0
HNS ward with a multidisciplina
team. As a surgeon his interest has
been in the ear, neuro-otology and
endoscopic cystorhinostomy (EDCR)
and sphenoid sinus surgery. .
As the head of Department of ORL-
HNS he has been at the helm in
innovating and improving the
undergraduate and postgraduate
studies especially in bioethical issues.
He was instrumental in setting the
ORL-HNS ward and the Audiology
"Hearing for all" centre. He also
spearheaded the formation of the
Audiology and speech unit, a service
unit under the Hospital and together
with the maxillofacial unit marks the
strong cooperation and symphony of
the ORL-HNS department. He has also
held other administrative posts in the
University such as the M.D. Phase III
chairman, Co-curriculum chairman a .
member of the curriculum commit
Currently he heads the ORL-H. __
conjoint board and planning to start a
new program in the School of Health
Sciences- BSc. in Audiology and BSc.
in Speech Pathology hopefully in 2004.
He has organised many workshops and
seminars; amongst others are the
Bone Anchored Hearing Aid workshop,
Hearing Seminars and ORL courses for
General Practitioners.
He also loves social services and
currently holds the post of president
of the Malaysian ORL-HNS society,
President of the Society for Helping the
Deaf, Kelantan (PEMANCAR). He was
also the School Board Chairman for
Sekolah Menengah Islam Aman (a
private school) when it started in 1997.
He is also one of the board members
for Rumah Raudatul Sakinah, a welfare
shelter home for girls with social
problems. His'ambition has always
Continuedon page 14
